Kymera Therapeutics' Series A Round

Kymera Therapeutics raised a round of funding on October 30, 2017.

Kymera Therapeutics is a biotechnology company that is developing an approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation and access…

Articles about Kymera Therapeutics' Series A Round: